The insights gained from the PCGP have direct implications for patient care. By identifying specific genetic mutations associated with different types of pediatric cancers, the project aids in the development of targeted therapies that are more effective and have fewer side effects compared to traditional treatments. Furthermore, the genetic information can be used to develop diagnostic tools that enable earlier detection and more accurate classification of cancers, improving prognosis and treatment outcomes.
